Evidence map›Paper›PMID 28720317›Full record

ArticleBiological psychiatry2018

DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence.

Lauren M Reynolds, Matthew Pokinko, Angélica Torres-Berrío, Santiago Cuesta, Laura C Lambert, Esther Del Cid Pellitero, Michael Wodzinski, Colleen Manitt, Paul Krimpenfort, Bryan Kolb and 1 more

Abstract read
In one paragraph

Article in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lauren M ReynoldsIntegrated Program in Neuroscience, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada; Departments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Matthew PokinkoIntegrated Program in Neuroscience, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada; Departments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Angélica Torres-BerríoIntegrated Program in Neuroscience, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada; Departments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Santiago CuestaDepartments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Laura C LambertDepartments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Esther Del Cid PelliteroDepartments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Michael WodzinskiDepartments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Colleen ManittDepartments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada.
Paul KrimpenfortDivision of Molecular Genetics, Centre for Biomedical Genetics, Cancer Genomics Centre, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bryan KolbCanadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, Alberta, Canada.
Cecilia FloresDepartments of Psychiatry and Neurology and Neurosurgery, McGill University, Douglas Mental Health University Institute, Montréal, Québec, Canada. Electronic address: cecilia.flores@mcgill.ca.
Douglas Mental Health University Institute · CAThe Netherlands Cancer Institute · NLUniversity of Lethbridge · CA

Funding

Amphetamine in adolescence disrupts frontal cortex developmentR01DA037911 · NIDA · MCGILL UNIVERSITY · PI FLORES, CECILIA · 2015 to 2024
$2.5M
Amphetamine During Adolescence Reroutes Mesolimbic Dopamine Axons to the Prefrontal Cortex via DCC SignalingF31DA041188 · NIDA · MCGILL UNIVERSITY · PI REYNOLDS, LAUREN MACKENZIE · 2016 to 2018
$99k
NIDA NIH HHS F31 DA041188NIDA NIH HHS R01 DA037911
6 · The paper itself

Abstract

backgroundDopaminergic input to the prefrontal cortex (PFC) increases throughout adolescence and, by establishing precisely localized synapses, calibrates cognitive function. However, why and how mesocortical dopamine axon density increases across adolescence remains unknown.

methodsWe used a developmental application of axon-initiated recombination to label and track the growth of dopamine axons across adolescence in mice. We then paired this recombination with cell-specific knockdown of the netrin-1 receptor DCC to determine its role in adolescent dopamine axon growth. We then assessed how altering adolescent PFC dopamine axon growth changes the structural and functional development of the PFC by quantifying pyramidal neuron morphology and cognitive performance.

resultsWe show, for the first time, that dopamine axons continue to grow from the striatum to the PFC during adolescence. Importantly, we discover that DCC, a guidance cue receptor, controls the extent of this protracted growth by determining where and when dopamine axons recognize their final target. When DCC-dependent adolescent targeting events are disrupted, dopamine axons continue to grow ectopically from the nucleus accumbens to the PFC and profoundly change PFC structural and functional development. This leads to alterations in cognitive processes known to be impaired across psychiatric conditions.

conclusionsThe prolonged growth of dopamine axons represents an extraordinary period for experience to influence their adolescent trajectory and predispose to or protect against psychopathology. DCC receptor signaling in dopamine neurons is a molecular link where genetic and environmental factors may interact in adolescence to influence the development and function of the prefrontal cortex.

Indexed as

AnimalsAttentionAxonsBehavior, AnimalDCC ReceptorDopaminergic NeuronsGene Knockdown TechniquesInhibition, PsychologicalMaleMaze LearningMiceNucleus AccumbensPrefrontal CortexSet, PsychologyDCC ReceptorAxon growthAxon-initiated recombinationBehavioral inhibitionCognitive flexibilityGuidance cuesNetrin-1

Identifiers

PMID28720317
PMCPMC5723533
OpenAlexW2626957219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.